Trials / Conditions / Nonseminomatous Germ Cell Tumor
Nonseminomatous Germ Cell Tumor
5 registered clinical trials studyying Nonseminomatous Germ Cell Tumor — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers NCT06967961 | Institut Claudius Regaud | N/A |
| Recruiting | Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer NCT06133543 | Heinrich-Heine University, Duesseldorf | N/A |
| Completed | CD30 CAR for CD30+ NSGCT NCT05634785 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Active Not Recruiting | Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors NCT03158064 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Terminated | Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors NCT02689219 | Nabil Adra | Phase 2 |